ODI Pharma7. Apr. 20202 Min.ODI Pharma AB: Status update in connection to COVID-19 ODI Pharma AB (“ODI” or “the Company”) hereby announces that the Board of Directors does not see any impact on the Company’s mid- and...
ODI Pharma27. Feb. 20203 Min.ODI Pharma AB: Publication of half-yearly report 2019ODI Pharma AB (“ODI” or “the Company”) hereby publishes its half-yearly report for the period October – December 2019. The report is...
ODI Pharma23. Jan. 20201 Min.Aphria Inc. received its EU-GMP certification ODI Pharma AB (“ODI Pharma” or “the Company”) hereby announce that Aphria Inc. (“Aphria”), the Company’s supplier of medical cannabis,...
ODI Pharma20. Jan. 20202 Min.Final registration of ODI Pharma’s new share issue completed Stockholm, 20.01.2020. As communicated earlier today, ODI Pharma AB's (“ODI Pharma” or “Company”) recently completed new share issue has...
ODI Pharma20. Jan. 20202 Min.First registration of ODI Pharma’s new share issue completed Stockholm, 20.01.2020. ODI Pharma AB's ("ODI Pharma" or "Company") recently completed new share issue was significantly oversubscribed...